Egypt vs Zimbabwe: Population requiring preventive chemotherapy for schistosomiasis
Egypt
2.98 million
in 2023
Zimbabwe
2.71 million
in 2024
Egypt rank
26th
Zimbabwe rank
27th
Population requiring preventive chemotherapy for schistosomiasis over time
- Egypt
- Zimbabwe
How they compare
Egypt currently reports 2.98 million against 2.71 million in Zimbabwe, a difference of 266,520.
That makes Egypt's figure about 1.1 times Zimbabwe's.
The two have swapped places 3 times across 14 shared years of data; in 2010 it was Zimbabwe ahead.
Egypt ranks 26th and Zimbabwe ranks 27th of 52 countries.
Across the 2 decades both report, Egypt averaged higher in 1 and Zimbabwe in 1.
Head to head by decade
| Decade | Egypt | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.76 million | 3.52 million | 1.76 million | Zimbabwe |
| 2020s | 2.94 million | 2.85 million | 95,835 | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Egypt or Zimbabwe?
- Egypt, at 2.98 million against 2.71 million in Zimbabwe as of 2023.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Egypt and Zimbabwe?
- 266,520, with Egypt ahead.
- How many years of comparable data are there for Egypt and Zimbabwe?
- 14 years are reported by both, from 2010 to 2023.
- How do Egypt and Zimbabwe rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Egypt ranks 26th and Zimbabwe ranks 27th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.